FDA clears Theradaptive’s OASIS pivotal trial as spinal fusion graft race enters a new phase
Spine biologics has long lacked fresh competition. Theradaptive’s OsteoAdapt SP trial could test whether that market is ready to move.
Medical Devices & Diagnostics